Headlines

Gilead Sciences (GILD) Q4 2025 (USD): EPS 1.86 (exp. 1.81), Revenue 7.93bln (exp. 7.69bln)

Newsquawk Staff ·

  • Raised quarterly dividend by 3.8% to 0.82/shr from 0.79.

Outlook

  • FY26 non-GAAP EPS 8.45-8.85 (exp. 8.79).

What it means

Gilead Sciences reported better-than-expected Q4 earnings with EPS of 1.86 against expectations of 1.81, indicating strong operational performance. The raised dividend reflects management's confidence in cash flows and future growth, while the FY26 EPS guidance also exceeds expectations, suggesting a positive outlook for the company's performance moving forward.

Related headlines